These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 8535910)
1. Endocrine and cytotoxic therapies for the management of advanced local breast cancer. Current clinical investigation. Parker LM; Bornstein BA Surg Oncol Clin N Am; 1995 Oct; 4(4):779-90. PubMed ID: 8535910 [TBL] [Abstract][Full Text] [Related]
2. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group. Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ; Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892 [TBL] [Abstract][Full Text] [Related]
3. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
5. [New combination chemotherapy regimens in the primary treatment of operable breast cancer]. Conti F; Sergi D; Foggi P; Abbate MI; Lopez M Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660 [TBL] [Abstract][Full Text] [Related]
6. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Buchholz TA; Hill BS; Tucker SL; Frye DK; Kuerer HM; Buzdar AU; McNeese MD; Singletary SE; Ueno NT; Pusztai L; Valero V; Hortobagyi GN Cancer J; 2001; 7(5):413-20. PubMed ID: 11693900 [TBL] [Abstract][Full Text] [Related]
7. Endocrine therapy and other targeted therapies for metastatic breast cancer. Hussain SA; Palmer DH; Moon S; Rea DW Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment for breast cancer in the elderly. Marchei P; Bianco V; Pignatelli E; Chiodini S; Santini D; Carico E; Marchei M; Vecchione A Anticancer Res; 1996; 16(2):911-3. PubMed ID: 8687150 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732 [TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466 [TBL] [Abstract][Full Text] [Related]
11. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973 [TBL] [Abstract][Full Text] [Related]
12. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for breast cancer. NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506 [TBL] [Abstract][Full Text] [Related]
14. Estradiol receptor and prognostic parameters of human breast cancer. Görlich M; Jandrig B Neoplasma; 1999; 46(2):112-6. PubMed ID: 10466435 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis. Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590 [TBL] [Abstract][Full Text] [Related]
16. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. Kaufmann M; Hortobagyi GN; Goldhirsch A; Scholl S; Makris A; Valagussa P; Blohmer JU; Eiermann W; Jackesz R; Jonat W; Lebeau A; Loibl S; Miller W; Seeber S; Semiglazov V; Smith R; Souchon R; Stearns V; Untch M; von Minckwitz G J Clin Oncol; 2006 Apr; 24(12):1940-9. PubMed ID: 16622270 [TBL] [Abstract][Full Text] [Related]
17. The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women. Mouridsen HT; Robert NJ Eur J Cancer; 2005 Aug; 41(12):1678-89. PubMed ID: 16098456 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929 [TBL] [Abstract][Full Text] [Related]
19. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182 [TBL] [Abstract][Full Text] [Related]
20. [Effective treatment strategy in elderly breast cancer patients]. Boér K Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]